This study aimed at evaluating the clinical relevance of plasmatic exosomes expressing PSA in a large cohort of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) patients, and in healthy subjects. The gene discussed is KLK3; the disease is prostate cancer.